CD4 and myeloid sarcoma: The high plasticity of Th17 cells was also recently evidenced in MS by Capone et al., who showed that human Th17 cells polarized from the naïve CD4+ T cells as well as from peripheral blood Th17 cells of RRMS patients display distinct inflammatory features compared to healthy donors.